Cannabis Stocks – Should Investors Buy Before 2023?

Cannabis stocks continue to climb on positive news from the United States, but should you invest before 2022 comes to an end?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

The New Year is fast approaching. Yet, 2023 is promising to be quite challenging. Economists believe that interest rates may continue to rise, especially with the Bank of Canada stating as much. That being said, many are also wondering if now is still the right time to invest.

After all, we may have already reached market bottom. Shares hit their lowest point of the year back in October 2022. Since then, the TSX is still down 7% year to date. However, that’s an improvement from the 18% we saw in the fall.

So while the future is uncertain, there may be some strong opportunities out there right now. In fact, one opportunity that may worth another look is cannabis stocks.

Why now?

Cannabis stocks have recently hit the headlines once more in the last few months for a number of reasons. First, President Joe Biden pardoned thousands of Americans for prior federal charges for simple marijuana possession. He then called on the government to review how marijuana is classified as a federal drug in the law.

Given this, cannabis stocks rose as it looked like there would be another move closer to, if not, legalization, decriminalization. Then, the momentum kept rolling.

During the recent state elections, three more states added the recreational use of marijuana to the legal column. Rhode Island, Maryland, and Missouri now make up the 21 states, two U.S. territories, and the District of Columbia where it’s recreationally legal.

That’s on top of the states that legalized medical use, with Mississippi legalizing it this year. With such major moves towards legalization, it’s clear why cannabis stocks have seen a bit of a rebound.

What this means for investors

With 2023 promising to be slow to start, we could continue to see a slow recovery. Then, there could be a strong period of growth in the second half of the year. Growth that could explode for high-growth (though high-risk) opportunities such as cannabis stocks.

This is why it’s important that investors learn from past mistakes. This is not a time in which we’re going to see any and every cannabis stock climb. Far from it. Investors are seeking out long-term opportunities instead. And in that sense, there are only two I would recommend.

Tilray and Canopy Growth

The two cannabis stocks I would still recommend considering before 2023, and beyond, are Tilray (TSX:TLRY) and Canopy Growth (TSX:WEED). These two offer investors growth in Canada, but far more of a global opportunity. Especially in the United States.

Tilray and Canopy are now the two potential companies that could be the largest marijuana producers and sellers in the entire world. Given that global marijuana sales hit US$13.2 billion in 2021, and are expected to reach US$102.2 billion by 2030, that’s an enormous market. But the U.S. is bound to be the largest contributor.

That’s why Tilray stock and Canopy stock look compelling as these companies continue to announce moves in this market. Canopy stock brought online its Acreage acquisition, for one. Tilray stock is making more partnerships in infused beverages and production companies, for another.

The future looks lit, but only for some

Cannabis stocks are still in for a rocky future. However, it’s a future that will stabilize with time. Think of this as like the beginning of mass alcohol legalization. There were some rocky times, to be sure. However, we’re now in a place where there are large alcohol companies with blue-chip status.

With a recovery perhaps on the way, I would consider getting in on cannabis stocks before 2023 is out. Because who knows what the New Year will bring, especially south of the border.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »